Novo-Nordisk A/S
NVO Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
$NVO is featured in our Tom Carper strategy.
See All StrategiesIncome
Balance Sheet
Cash Flow
NVO Income Statement
NVO Balance Sheet
NVO Cash Flow
Recent trades of NVO by members of U.S. Congress
NVO Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
NVO Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
NVO Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NVO's directors and management
Government lobbying spending instances
-
$780,000 Oct 18, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
-
$1,060,000 Jul 19, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
-
$1,490,000 Apr 18, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
-
$2,180,000 Apr 18, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
-
$60,000 Feb 07, 2024 Issue: Budget/Appropriations Pharmacy Medicare/Medicaid Health Issues
-
$600,000 Oct 19, 2023 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
-
Patent Title: Process for spray drying a glp-1 peptide Nov. 12, 2024
-
Patent Title: Pill bottle Oct. 29, 2024
-
Patent Title: Factor vii (fvii(a))/trem-like transcript 1 (tlt-1) bispecific antibodies Oct. 22, 2024
-
Patent Title: Insulin analogues and uses thereof Oct. 22, 2024
-
Patent Title: Medical device with actuation mechanism Oct. 22, 2024
-
Patent Title: Site directed mutagenesis of trem-1 antibodies for decreasing viscosity Oct. 15, 2024
-
Patent Title: Amylin receptor agonists Oct. 15, 2024
-
Patent Title: Drug delivery device with dose counting mechanism Oct. 15, 2024
-
Patent Title: Torsion spring driven injection device Oct. 08, 2024
-
Patent Title: Basal titration with adaptive target glucose level Oct. 08, 2024
-
Patent Title: Highly potent isvd compounds capable of substituting for fviii(a) Sep. 24, 2024
-
Patent Title: Procoagulant antibodies Sep. 10, 2024
-
Patent Title: Cnp compounds Sep. 03, 2024
-
Patent Title: Automatic injection device with a top release mechanism Aug. 27, 2024
-
Patent Title: Pill Aug. 20, 2024
-
Patent Title: Co-agonists of the glp-1 and amylin receptors Aug. 06, 2024
-
Patent Title: Semaglutide in medical therapy Jul. 09, 2024
-
Patent Title: Mating factor alpha pro-peptide variants Jul. 02, 2024
-
Patent Title: Housing for a medical injection device Jun. 25, 2024
-
Patent Title: Mic-1 compounds and use thereof Jun. 11, 2024
-
Patent Title: Accessory device for drug delivery device May. 21, 2024
-
Patent Title: Drug delivery device with a hydraulic trigger mechanism May. 14, 2024
-
Patent Title: Compositions and methods for inhibiting transmembrane serine protease 6 (tmprss6) expression Apr. 09, 2024
-
Patent Title: Multi-use drug delivery device for drugs with less preservatives Apr. 02, 2024
-
Patent Title: Drug injection device with deflectable transducer Mar. 19, 2024
-
Patent Title: Anti-transthyretin antibodies Feb. 27, 2024
-
Patent Title: Lyophilized formulation of a monoclonal antibody against transthyretin Jan. 16, 2024
-
Patent Title: Nucleic acids encoding antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1) Jan. 02, 2024
-
Patent Title: Prodrugs and uses thereof Dec. 12, 2023
-
Patent Title: Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid Dec. 05, 2023
-
Patent Title: Apoc-ii mimetic peptides Nov. 28, 2023
-
Patent Title: Factor x binders enhancing fx activation Oct. 17, 2023
-
Patent Title: Dchbs-active esters of peg compounds and their use Oct. 17, 2023
-
Patent Title: Anti-angptl3 antibodies suitable for high concentration compositions and subcutaneous administration Oct. 10, 2023
-
Patent Title: Co-agonists at glp-1 and gip receptors suitable for oral delivery Oct. 10, 2023
-
Patent Title: Glucose-sensitive albumin-binding derivatives Sep. 26, 2023
-
Patent Title: Accessory device with mounting feature for engaging dial member Sep. 19, 2023
-
Patent Title: Compositions of glp-1 peptides and preparation thereof Sep. 19, 2023
-
Patent Title: Compositions of glp-1 peptides and preparation thereof Sep. 19, 2023
-
Patent Title: Compositions of glp-1 peptides and preparation thereof Sep. 19, 2023
-
Patent Title: Compounds for treatment of obesity Sep. 12, 2023
-
Patent Title: Glp-1 compositions and uses thereof Sep. 12, 2023
-
Patent Title: Selective elimination of erosive cells Jul. 11, 2023
-
Patent Title: Drug delivery system with multipolar magnet and sensor system Jun. 27, 2023
-
Patent Title: Method for using insulin degludec for the improvement of glycemic control and reduction of acute and long-term diabetes complications Jun. 13, 2023
-
Patent Title: Cartridge holder assembly for drug delivery device Jun. 13, 2023
-
Patent Title: Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (marc1) expression May. 23, 2023
-
Patent Title: Bifunctional compounds comprising insulin peptides and egf(a) peptides May. 16, 2023
-
Patent Title: Power unit for drug delivery device May. 16, 2023
-
Patent Title: Spring straining mechanism for torsion spring based device Apr. 25, 2023
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of NVO in WallStreetBets Daily Discussion
NVO News
Recent insights relating to NVO
CNBC Recommendations
Recent picks made for NVO stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NVO
NVO Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NVO Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More